9342-8530 Quebec Inc DGCRF

agree but

[ready2go1]

there are many positives that both Diagnocure/Hologic refuse to share with investors. Its a shame that they do not update patients on the labs/hospitals that have adopted pca3. As cur2004 posted, there are many that jump on board on a weekly basis; it would be great to see the list and it would move the share price if Diagnocure would at least release news when the major institutions here in the U.S. begin to offer the test and share some of the comments from their Urologists. Sales are picking up but I still believe that we are at least 6 months behind what diagnocure reports. I can't imagine that Hologic wants to see the jump from 8% to 16% that will happen later this year. Thats a huge jump that they will have to share with CUR and will ignite the share price and I expect hologic to acquire before that happens. In the mean time, we should have never dropped below $1 and should climb back there soon. We moved down on nothing these past several months. Diagnocure has doctors running the company and do a good job taking care of patients but they are not CEO's and have no clue how to keep a market in touch with what is taking place with the company. I would never have a earnings report on Friday after the bell. I have no reason to complain because it has given us time to buy but I want to see us make the jump that CNBC talked about back when we were at $2.40.

The news is there but we just have to do all the work to find it.